We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Expands Joint Review Pilot for Generics Applications
EMA Expands Joint Review Pilot for Generics Applications
The European Medicines Agency has extended a pilot program that allows generics manufacturers to make joint submissions to the agency and regulators in Australia, Canada, Taiwan and Switzerland.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor